Europe’s Horizon 2020 reserach program funding and implications

A New York Times article (Dec 2, 2011) describes the European research fund, Horizon 2020, set to provide $108 billion in funding from 2014 to 2020. But this funding, aimd at innovations in food, health, transport, clean energy etc, requires initial deployment of the technology in Europe, potentially creating manufacturing there.  What are the implications for US manufacturers wanting to avail of this funding – is the constraint worth the funding? How will it impact initial vs steady state supply chain structure for new products that have to conform to the constraint ? Will a market first in Europe constraint be sufficient to cause companies to manufacture in Europe, if that would not be their unconstrained choice ?

Advertisements

About aviyer2010

Professor
This entry was posted in Global Contexts, Operations Management, Supply Chain Issues and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s